Gene editing startup Metagenomi files for an IPO

Metagenomi, a biotechnology startup working to identify new CRISPR enzymes for editing genes, has filed to go public.
Backed by healthcare investors and pharmaceutical firms including Novo Nordisk’s parent company and Bayer’s venture arm, Metagenomi most recently raised a $275 million Series B round.